Mr. Ellberger has served as a member of the Board of Directors since March 2014. He is Chairman of the Board of Celldex Therapeutics, Inc. and is a Founder and Principal of Healthcare Ventures Associates, Inc., a consulting firm for the pharmaceutical, biotechnology and medical device industries. He was most recently Interim CEO of PDI, Inc., a diversified sales and marketing services provider to the biopharmaceutical, medical device and diagnostic industries. From 2000 to 2003, he was Senior Vice President of Powderject plc, where he also served as a director. Mr. Ellberger is currently on the board of directors of Transpharma, Ltd. and The Jewish Children’s Museum and was Chairman of the board of Omrix Biopharmaceuticals Ltd. until its acquisition by Johnson & Johnson in 2008.